AstraZeneca
AZN
#47
Rank
HK$2.173 T
Marketcap
HK$700.86
Share price
-0.90%
Change (1 day)
37.71%
Change (1 year)

Operating Margin for AstraZeneca (AZN)

Operating Margin as of December 2025 (TTM): 16.07%

According to AstraZeneca's latest financial reports and stock price the company's current Operating Margin is 16.07%. At the end of 2024 the company had an Operating Margin of 16.07%.

Operating Margin history for AstraZeneca from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202416.07%6.73%
202315.06%167.06%
20225.64%-896.22%
2021-0.71%-104.81%
202014.71%131.75%
20196.35%-29.64%
20189.02%-8.99%
20179.91%-35.8%
201615.44%24.32%
201512.42%164.64%
20144.69%-62.93%
201312.66%-53.68%
201227.33%-25.25%
201136.57%10.82%
201032.99%0.15%
200932.94%19.92%
200827.47%1.72%
200727.01%-16.3%
200632.27%15.92%
200527.84%23.13%
200422.61%4.52%
200321.63%-11.55%
200224.45%-5.35%
200125.84%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Bristol-Myers Squibb
BMY
16.72% 4.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
12.60%-21.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06% 93.28%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
22.01% 36.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
15.12%-5.91%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
37.87% 135.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
18.78% 16.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
18.56% 15.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
18.91% 17.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
29.12% 81.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.